Lead Product(s) : Gonadorelin Acetate
Therapeutic Area : Endocrinology
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
LutrePulse Hypogonadotropic Hypogonadism
Details : Gonadorelin Acetate is a Protein drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Amenorrhea-associated with Hypogonadotropic Hypogonadism.
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
November 06, 2013
Lead Product(s) : Gonadorelin Acetate
Therapeutic Area : Endocrinology
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
